from admin | Sep 26, 2022 | News
August 2022 - Jama Dermatology DOI:10.1001/jamadermatol.2022.2044 Although isotretinoin may rarely be associated with laboratory abnormalities such as hypertriglyceridemia, the optimal approach to monitoring...
from admin | Sep 26, 2022 | News
August 2022 - JAMA Dermatology DOI:10.1001/jamadermatol.2022.2721 From this double-blinded case-control study 891 participants with multiple molluscum contagiosum (3 to 70), aged over six months used, a...
from admin | Sep 26, 2022 | News
July 2022 - Medscape When adolescents have acne that does not respond to isotretinoin, it is necessary to ensure that they take the drug along with fatty foods, which are known to increase its bioavailability. So advises James R....
from admin | Sep 26, 2022 | News
July 2022 The US Food and Drug Administration has approved topical ruxolitinib (Opzelura) for the treatment of nonsegmental vitiligo in patients 12 years of age and older. The Janus kinase 1/JAK2 inhibitor, formulated as a cream had been...
from admin | Sep 26, 2022 | News
June 2022 The Food and Drug Administration approved (on June 7, 2022) Dupilumab as an adjunctive maintenance treatment for children aged 6 months to 5 years with moderate to severe atopic dermatitis whose disease is not adequately...